Ten largest shareholders as of November 23, 2023
NameSeries A sharesSeries B sharesShare capital %Voting rights %
ANNWALL & ROTHSCHILD INVESTMENT AB453 283721 3518.7229.93
SIX SIS AG, W8IMY01 483 42311.018.45
FJÄRDE AP-FONDEN01 344 0009.987.66
NORTHERN TRUST COMPANY01 007 0947.485.74
AMF AKTIEFOND0601 9024.473.43
TREDJE AP-FONDEN0601 8944.473.43
UNIONEN0532 0233.953.03
SEB AB, LONDON0431 4293.202.46
ÅLANDSBANKEN ABP0403 2452.992.30
DANGOOR, DAVID0367 7052.732.10
Sub-total453 2837 494 06659.0068.53
Other shareholders05 524 07141.0031.47
Total453 28313 018 137100.00100.00
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 453,283 class A shares with 10 votes per share and 13,018,137 class B shares with one vote per share, in total 13,471,420 shares.